{
"info": {
"nct_id": "NCT00383331",
"official_title": "A Phase II Study of ALIMTA® (Pemetrexed) and GEMZAR® (Gemcitabine) Every 14 Days Versus Pemetrexed and Gemcitabine Every 21 Days in Advanced Non-Small Cell Lung Cancer",
"inclusion_criteria": "* histologic or cytologic diagnosis of NSCLC Stage IIIB or IV\n* no prior systemic chemotherapy for advanced Non-Small Cell Lung Cancer\n* Prior radiotherapy must be completed at least 4 weeks before study enrollment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* estimated life expectancy of 12 weeks\n* a serious cardiac condition, such as myocardial infarction within 6 months, angina, or heart disease\n* documented brain metastases unless the patient has completed successful local therapy for central nervous system metastases and has been off of corticosteroids for at least 2 weeks before enrollment\n* significant weight loss (that is, > 10%) over the previous 6 weeks before study entry.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* histologic or cytologic diagnosis of NSCLC Stage IIIB or IV",
"criterions": [
{
"exact_snippets": "histologic or cytologic diagnosis of NSCLC",
"criterion": "NSCLC diagnosis",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologic",
"cytologic"
]
}
]
},
{
"exact_snippets": "Stage IIIB or IV",
"criterion": "NSCLC stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"IIIB",
"IV"
]
}
]
}
]
},
{
"line": "* no prior systemic chemotherapy for advanced Non-Small Cell Lung Cancer",
"criterions": [
{
"exact_snippets": "no prior systemic chemotherapy",
"criterion": "prior systemic chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "advanced Non-Small Cell Lung Cancer",
"criterion": "Non-Small Cell Lung Cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "advanced"
}
]
}
]
},
{
"line": "* Prior radiotherapy must be completed at least 4 weeks before study enrollment.",
"criterions": [
{
"exact_snippets": "Prior radiotherapy must be completed at least 4 weeks before study enrollment.",
"criterion": "prior radiotherapy",
"requirements": [
{
"requirement_type": "completion time",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* estimated life expectancy of 12 weeks",
"criterions": [
{
"exact_snippets": "estimated life expectancy of 12 weeks",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* a serious cardiac condition, such as myocardial infarction within 6 months, angina, or heart disease",
"criterions": [
{
"exact_snippets": "a serious cardiac condition, such as myocardial infarction within 6 months",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "a serious cardiac condition, such as ... angina",
"criterion": "angina",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "a serious cardiac condition, such as ... heart disease",
"criterion": "heart disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* documented brain metastases unless the patient has completed successful local therapy for central nervous system metastases and has been off of corticosteroids for at least 2 weeks before enrollment",
"criterions": [
{
"exact_snippets": "documented brain metastases",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "completed successful local therapy for central nervous system metastases",
"criterion": "local therapy for central nervous system metastases",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
},
{
"requirement_type": "success",
"expected_value": true
}
]
},
{
"exact_snippets": "off of corticosteroids for at least 2 weeks before enrollment",
"criterion": "corticosteroid use",
"requirements": [
{
"requirement_type": "duration off",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* significant weight loss (that is, > 10%) over the previous 6 weeks before study entry.",
"criterions": [
{
"exact_snippets": "significant weight loss ... > 10% ... over the previous 6 weeks",
"criterion": "weight loss",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 10,
"unit": "%"
}
},
{
"requirement_type": "time frame",
"expected_value": "previous 6 weeks"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}